- Home
- CTMX vs API Comparison
CTMX vs API Comparison
Compare CTMX & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- API
- Stock Information
- Founded
- CTMX 2008
- API 2013
- Country
- CTMX United States
- API United States
- Employees
- CTMX N/A
- API N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- API Computer Software: Prepackaged Software
- Sector
- CTMX Health Care
- API Technology
- Exchange
- CTMX Nasdaq
- API Nasdaq
- Market Cap
- CTMX 380.9M
- API 343.2M
- IPO Year
- CTMX 2015
- API 2020
- Fundamental
- Price
- CTMX $1.91
- API $3.67
- Analyst Decision
- CTMX Strong Buy
- API Strong Buy
- Analyst Count
- CTMX 3
- API 1
- Target Price
- CTMX $5.67
- API $6.00
- AVG Volume (30 Days)
- CTMX 3.1M
- API 377.7K
- Earning Date
- CTMX 08-07-2025
- API 08-18-2025
- Dividend Yield
- CTMX N/A
- API N/A
- EPS Growth
- CTMX 263.20
- API N/A
- EPS
- CTMX 0.49
- API N/A
- Revenue
- CTMX $141,100,000.00
- API $133,504,000.00
- Revenue This Year
- CTMX N/A
- API $7.10
- Revenue Next Year
- CTMX N/A
- API $10.91
- P/E Ratio
- CTMX $3.91
- API N/A
- Revenue Growth
- CTMX 18.01
- API N/A
- 52 Week Low
- CTMX $0.40
- API $1.65
- 52 Week High
- CTMX $3.10
- API $6.99
- Technical
- Relative Strength Index (RSI)
- CTMX 39.81
- API 42.46
- Support Level
- CTMX $1.72
- API $3.71
- Resistance Level
- CTMX $2.43
- API $3.97
- Average True Range (ATR)
- CTMX 0.20
- API 0.17
- MACD
- CTMX -0.06
- API -0.02
- Stochastic Oscillator
- CTMX 26.84
- API 26.67
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.